CHRS Coherus Oncology, Inc.
$1.33▼ -0.75%
Healthcare
Other
After hours
$1.35▲ +1.50%
Sep 11, 7:30 PM ET
Volume 528.8K
Avg Volume (10D) 698.8K
Key Metrics & Fundamentals
Market Cap
$205.49M
P/E Ratio
–
Div Yield
–%
52W Range
1.09 - 2.62
% vs 50 MA
-4.68%
% vs 200 MA
-15.59%
RSI-14
46.9
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.89
Free Cash Flow
-$62.09M
Gross Rev
$14.31M
Gross Profit
$10.07M
EBITDA
-$30.16M
COGS
$4.24M
Operating Exp
$42.40M
Operating Income
-$32.33M
EBIT
-$32.33M
Pretax Income
-$33.35M
Net Income
-$20.63M
EPS (Diluted)
-0.13
Price & Volume History
Loading chart…
Recent News
Coherus to Participate in Upcoming Investor Conferences
GlobeNewswire · Aug 31, 2026 1:30 PM
Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights
GlobeNewswire · Aug 17, 2026 9:33 PM
Coherus Oncology (CHRS) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 13, 2026 12:31 AM
Coherus Oncology, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 6, 2026 12:30 PM
Coherus Oncology Inc (CHRS) (Q2 2026) Earnings Call Highlights: LOQTORZI Growth and Pipeline ...
GuruFocus.com · Aug 6, 2026 5:03 AM
Coherus Oncology Q2 Earnings Call Highlights
MarketBeat · Aug 6, 2026 12:04 AM
Coherus Oncology (CHRS) Reports Q2 Loss, Misses Revenue Estimates
Zacks · Aug 5, 2026 10:10 PM
Coherus Oncology: Q2 Earnings Snapshot
Associated Press · Aug 5, 2026 9:07 PM
Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · Aug 5, 2026 8:28 PM
Coherus Oncology to Report Second Quarter 2026 Financial Results on August 5, 2026
GlobeNewswire · Jul 22, 2026 5:36 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See CHRS's money flow as a full page
Social Sentiment
Avg +0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.